• Philip Morris International Q3 2026 Earnings Analysis
    Oct 21 2026
    More earnings analysis: https://betafinch.com
    Groups: INCOME (https://betafinch.com/groups/INCOME)
    ──────────
    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Philip Morris International's third quarter 2026 results. This one's got a little bit of everything — record profits, a big strategic pivot in the U.S., and some real geopolitical headwinds.

    Before we jump in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Okay Alex, let's start with the headline numbers because they're honestly pretty strong. PMI posted organic net revenue growth of 7.1% in Q3, hitting $11.4 billion. Adjusted operating income crossed $5 billion for the first time ever, and margins hit almost 45%.

    **ALEX:** That's a big one. And EPS came in at $2.36, a new quarterly record, up about 6% excluding currency effects. So on the surface, this is a "records across the board" quarter.

    **JORDAN:** Right, but there's nuance. CFO Massimo Andolina was pretty transparent that full-year guidance is now trending toward the middle-to-lower half of their ranges — both for operating income growth and EPS growth. And it's not because the core business is struggling. It's really two things: geopolitical cost pressure from the Middle East and Ukraine conflicts, and a massive, intentional investment surge in the U.S.

    **ALEX:** Let's talk about the smoke-free story first, because that's really the heart of PMI's whole transformation. Smoke-free products now make up 40% of total revenue, and in over 30 markets, they're already more than half of revenue. IQOS, their heated tobacco brand, saw adjusted in-market sales growth accelerate to 7.1% — or over 10% if you strip out Japan and Poland, which both have unique headwinds right now.

    **JORDAN:** Japan's going through this bumpy excise tax transition — they raised taxes twice this year on heated tobacco specifically, which caused some pantry-loading distortions in the data. Poland's dealing with a flavor ban. But outside those two, the growth story is honestly remarkable — double-digit IMS growth in Italy, Greece, Spain, Germany, the Netherlands, UK. And get this — their international heated tobacco and cigarette combined market share crossed 30% for the first time ever.

    **ALEX:** And then there's VEEV, their e-vapor brand — shipments up 62% in the quarter, becoming the number one closed pod brand in Europe. That's a smaller piece of the pie but growing incredibly fast.

    **JORDAN:** Now let's get into the part everyone's really watching — the U.S. and ZYN. This is where it gets interesting, and honestly, a little messy in the near term.

    **ALEX:** So ZYN had a rough patch earlier this year with volume growth below the category rate. Management's answer was a two-pronged strategic overhaul. First, they're massively expanding the product lineup — new flavors, new nicotine strengths including ZYN Ultra at 9 and 11 milligrams — basically chasing consumers who'd drifted to competitors for higher-nicotine options.

    **JORDAN:** And it seems to be working — they said category offtake share increased about 1.4 points from June to September. But the second piece is the bigger deal: they're repositioning pricing by moving their flagship cans from 15 pouches to 20 pouches at the same price. Andolina called it a value proposition improvement for consumers, but mathematically, that's roughly a 25% cut in revenue per pouch.

    **ALEX:** That's a huge deal. And combined with the step-up in marketing spend — U.S. SG&A hit around $370 million in Q3 with another 10% sequential jump expected in Q4 — the company is basically telling investors: expect U.S. profitability to be near zero or even slightly negative next quarter.

    **

    This episode includes AI-generated content.
    Show More Show Less
    8 mins
  • Philip Morris International Q2 2026 Earnings Analysis
    Jul 22 2026
    More earnings analysis: https://betafinch.com
    Groups: INCOME (https://betafinch.com/groups/INCOME)
    ──────────
    Welcome to Beta Finch, your AI-powered earnings breakdown of the biggest names in the market. Here's the script for PMI's Q2 2026 call.

    ---

    **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Philip Morris International's second quarter 2026 results — and there's a lot going on here, including a CFO transition. But first, the standard stuff: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN:** Right, and PMI gave us plenty to unpack. Let's start with the headline numbers, because they were strong.

    **ALEX:** Very strong. Organic net revenue growth of +8% for the quarter, operating income up +11%, and adjusted diluted EPS hit $2.20 — that's +14% currency-neutral, +15% in dollar terms. Quarterly net revenue crossed $11 billion for the first time ever.

    **JORDAN:** And this wasn't just a currency tailwind story either. Outgoing CFO Emmanuel Babeau flagged that about a third of the EPS beat came from a favorable tax-related currency effect tied to the Russian ruble, but two-thirds was real operating strength — better SG&A phasing and a surprisingly strong combustible business.

    **ALEX:** Let's talk about that smoke-free business first, because it's really the engine of this whole story. IQOS adjusted in-market sales volume grew +5% in the quarter — that sounds almost modest until you realize it includes two known headwinds: an excise tax hike in Japan and a flavor ban in Poland.

    **JORDAN:** Strip those out and IQOS growth was over 10% in Q2, north of 11% for the first half. That's the real underlying trend. IQOS also just cracked Kantar's list of top 100 most valuable global brands — pretty remarkable for a product that's only a decade old.

    **ALEX:** VEEV, their vapor brand, had an absolutely wild quarter — shipments up 55% in Q2, 72% for the half. Management says it's now the number one closed-pod brand in Europe and in global travel retail.

    **JORDAN:** Now let's get into the U.S., because this is where investors have been the most impatient. ZYN shipments grew 2% year-over-year to 2.9 billion pouches, and importantly, that's despite lapping an inventory tailwind from last year. Sequentially versus a rough Q1, U.S. net revenue was up 38%, gross profit up 46%.

    **ALEX:** The bigger story is the product lineup. They just launched ZYN Ultra — a lower-priced moist variant meant to close the gap with competitors — and they're bringing 1.5 and 8 milligram dry formats in Q3. Babeau was pretty clear-eyed that it's early days, just two weeks of data on Ultra, but the initial read and consumer feedback were encouraging.

    **JORDAN:** And there's a regulatory tailwind too — ZYN got Modified Risk Tobacco Product authorization on 20 SKUs, the only nicotine pouch product with that designation. That lets them actually market reduced-risk claims versus cigarettes, which is a real differentiator.

    **ALEX:** Here's the strategic pivot that stood out to me: management is choosing to step up U.S. investment hard in the second half — more marketing, a new brand campaign called "When It Clicks," expanded distribution — partly to build ZYN and partly to lay the groundwork for IQOS ILUMA's eventual U.S. launch, pending FDA action.

    **JORDAN:** Which is why, despite beating estimates two quarters in a row, PMI held its full-year guidance rather than raising it. An analyst from Goldman actually pushed on this directly, and Babeau basically confirmed: yes, the flat guidance reflects the decision to plow incremental profit back into U.S. investment rather than let it drop straight to the bottom line.

    **ALEX:** Let's touch on combustibles too, because cigarettes had a surprisingly strong quart

    This episode includes AI-generated content.
    Show More Show Less
    8 mins
  • Philip Morris International Q4 2025 Earnings Analysis
    Feb 27 2026
    **BETA FINCH PODCAST SCRIPT**

    ---

    **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Philip Morris International's Q4 2025 earnings call. Now before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

    **JORDAN**: Thanks Alex! And what a call this was from Philip Morris. They absolutely crushed it in 2025, delivering what CEO Jacek Olczak called "another outstanding year." We're talking about their fifth consecutive year of positive volumes, driven primarily by their smoke-free products business.

    **ALEX**: Right, and the numbers really tell the story here. Philip Morris hit over $40 billion in total net revenues for 2025, with smoke-free products now representing 41.5% of that - nearly $17 billion! That's a massive shift from where they were just a few years ago.

    **JORDAN**: The growth trajectory is impressive. Smoke-free product volumes grew 12.8%, with IQOS leading the charge at 11% growth. But here's what caught my attention - their ZYN nicotine pouches in the US grew shipments by 37%, despite supply constraints. That's reaching 11.9 billion pouches, making up about 7% of their total smoke-free volume.

    **ALEX**: And let's talk profitability because that's where this story gets really interesting. Their smoke-free gross margin hit 69.5%, which is now four percentage points higher than their combustible business. CFO Emmanuel Babeau made it clear that this improving profitability mix is a key driver of their overall margin expansion.

    **JORDAN**: Speaking of margins, they delivered 140 basis points of organic margin expansion to reach 40.4% adjusted operating margin. That's while they're still investing heavily in marketing and brand building for their smoke-free portfolio. It shows real operating leverage in the business model.

    **ALEX**: Now, the guidance for 2026 is where things get particularly interesting. They're forecasting organic net revenue growth of 5-7%, which might seem modest compared to recent years, but there are some specific headwinds they're navigating.

    **JORDAN**: Exactly. The big story is Japan, where they're facing significant excise tax increases on heated tobacco products - we're talking 50-100 yen per pack, which could be 10-20% of current retail prices. This creates an asymmetry where heated tobacco gets hit first, before cigarettes face similar increases in 2027.

    **ALEX**: And in the US, there's the ZYN inventory normalization. They estimate there are about 25 million cans of surplus inventory in the downstream supply chain that needs to work through, likely in Q1. But the underlying demand story remains strong - ZYN maintained about 61.5% volume share in the US nicotine pouch category.

    **JORDAN**: What I found fascinating in the Q&A was the discussion around ZYN Ultra, their higher-strength nicotine pouch that's pending FDA approval. Olczak was pretty direct - they have readiness to launch "essentially as we speak," and they're expecting some movement this summer, though he admitted he doesn't have a great track record forecasting the FDA!

    **ALEX**: [Laughs] At least he's honest about that! But you can tell they're frustrated with the regulatory environment. When asked about New York's proposed excise tax on nicotine pouches, Olczak called it "counterproductive to the health benefits" and "the wrong idea."

    **JORDAN**: The international expansion story is really compelling too. They're now in 106 markets with smoke-free products, and some of these new launches are showing impressive traction. Taiwan caught my eye - they hit 4% market share in just a few weeks after launch. That's remarkable penetration for a new market entry.

    **ALEX**: And they're not just focused on IQOS any

    This episode includes AI-generated content.
    Show More Show Less
    8 mins
  • Coming Soon - Beta Finch EN
    Feb 17 2026
    Stay tuned for AI-powered earnings analysis from Beta Finch.

    This episode includes AI-generated content.
    Show More Show Less
    2 mins